CCSL Launches pharmainteractive.com
The complete learning management solution for the industry.
CCSL are pleased to announce the launch of a new dedicated e-Learning product for the pharmaceutical industry. PharmaInteractive™ was developed recognizing that good quality training need not require absenteeism from work, travel and expensive course fees. PharmaInteractive is available as both subscription- and license-based content with an objective to encourage training across a broad range of relevant topics. PharmaInteractive offers pick’n’mix, or modular access to off-the-shelf training elements, or company-specific customizable components.
PharmaInteractive provides narrated illustrated presentations with interactive features, including time-lines, pop-down glossaries, notes, and biographies to ensure that participants remain informed and retain interest throughout. After each lecture, lasting 20-30 mins, participants are offered a short quiz incorporating varying solution formats. When they meet the accreditation standard, they are automatically and immediately offered a completed training certificate, and their training records are updated.
In addition, PharmaInteractive has Chatrooms and Forums in general and specialist topic themes, as well as News pages which are based on the contributions of the users. The site is supported by expert Faculty Administrators who are available on-line, including their regular live participation in the Chatrooms to assist with the training experience. In combination, these unique capabilities consolidate knowledge and provide interpretation. Line managers are nominated by the participants and are able to access the training records of their staff to ensure they are meeting their training objectives.
The presentations are competitively priced, between £15 and £50 each, with package and other discounted options. PharmaInteractive is currently available for PHARMACOVIGILANC. Other specialities will be announced shortly.
Further information, contact services@pharmainteractive.com 
More news from this company